Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell TransplantationOriginal Research Published on 2021-08-272024-09-02 Journal: Frontiers in Medicine [Category] 대상포진, [키워드] bortezomib Chemotherapy Chemotherapy resistance melphalan Myeloma [DOI] 10.3389/fmed.2021.712070 PMC 바로가기 [Article Type] Original Research
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment골수종 환자의 Covid-19 백신 접종 후 중화 항체 반응은 항-미 일종 치료의 유형에 크게 의존합니다.Multicenter Study Published on 2021-08-022022-09-01 Journal: Blood Cancer Journal [Category] MERS, SARS, 임상, 진단, 치료법, [키워드] active treatment anti-CD38 antibodies antibody Antibody Response AZD1222 belantamab mafodotin BNT162b2 Cell Comparisons Control COVID-19 vaccination dependent on dose enrolled evaluated healthy control Hematological malignancies humoral independent infection control leads lymphopenia mAbs MAFODOTIN measure monoclonal antibody Myeloma NAb nAb response NAbs neoplasm Neutralizing antibodies Neutralizing antibody response non-responders Patient plasma Plasma cell Prognostic factor recent responders SARS-CoV-2 SARS-CoV-2 vaccination Treatment vaccination Vaccine [DOI] 10.1038/s41408-021-00530-3 PMC 바로가기 [Article Type] Multicenter Study
Response to mRNA vaccination for COVID-19 among patients with multiple myelomaArticle Published on 2021-07-292023-07-02 Journal: Leukemia [Category] SARS, [키워드] Myeloma public health [DOI] 10.1038/s41375-021-01354-7 PMC 바로가기 [Article Type] Article
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 TreatmentArticle Published on 2021-07-282022-10-31 Journal: Cancers [Category] COVID-19, [키워드] age Anti-SARS-CoV-2 antibody response anti-SARS-CoV-2 vaccination anti-SARS-CoV-2 vaccine anti-SARS-CoV-2 vaccines anti-SARS-CoV-2-antibody Antibody titer Antibody titers B lymphocyte booster vaccination CD19+ Cell clinical factor correlated count COVID-19 pandemic current therapy cut-off value disease dyscrasia Efficacy first dose first vaccination Hematological malignancies immunomodulatory drug Linear regression majority mRNA Multiple Multiple myeloma multivariable Myeloma Patient patients plasma positive receiving reduced respond poorly response SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccination SARS-CoV-2 vaccine significantly significantly higher simple single-center study Treatment Vaccines [DOI] 10.3390/cancers13153800 PMC 바로가기 [Article Type] Article
Moraxella Bacteremia in Cancer Patientsarticle Published on 2021-05-292024-09-02 Journal: Cureus [Category] 대상포진, [키워드] Immunocompromised patient Moraxella Myeloma Pneumonia respiratory tract [DOI] 10.7759/cureus.15316 PMC 바로가기 [Article Type] article
Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma다발성 골수종 환자에서 심각한 COVID-19 감염에 대한 인터루킨-6(IL-6) 차단의 의미Article Published on 2021-05-122022-09-12 Journal: Acta bio-medica : Atenei Parmensis [Category] SARS, 진단, [키워드] Multiple Myeloma Patient Severe COVID-19 Infection [DOI] 10.23750/abm.v92i2.11395 PMC 바로가기 [Article Type] Article
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western ChinaResearch Paper Published on 2021-03-052024-09-02 Journal: Journal of Cancer [Category] 대상포진, [키워드] B cell bortezomib Myeloma Prognosis Real world [DOI] 10.7150/jca.53209 PMC 바로가기 [Article Type] Research Paper
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK)Article Published on 2021-03-012023-07-13 Journal: British Journal of Haematology [Category] SARS, [키워드] Infection Myeloma myeloma treatment. [DOI] 10.1111/bjh.17261
Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case reportCOVID-19 감염 후 재발 및 불응성 다발성 골수종 환자에서 항BCMA CAR T 투여: 증례 보고Case Reports Published on 2021-02-192022-09-12 Journal: Journal of Medical Case Reports [Category] MERS, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration Antigen antigen receptor antiviral antibodies antiviral antibody benefit Cancer patients CAR CAR T cell Case report Cell Cell therapy Chemotherapy chimeric antigen receptor clinical recovery clinical study Complete coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19-related complications criteria CRS Cytokine release syndrome decision detectable dose Enrollment exacerbate global pandemic group Host immune immune response Immunosuppression infections initial male maturation Multiple myeloma Myeloma novel Novel coronavirus novel coronavirus disease pandemic Patient potential risk proceed receiving Registered risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus severe acute respiratory syndrome Coronavirus susceptible T cell the patient the SARS-CoV-2 virus therapy treated Treatment viral infection working [DOI] 10.1186/s13256-020-02598-0 PMC 바로가기 [Article Type] Case Reports
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)Article Published on 2021-02-012024-09-02 Journal: Blood Cancer Journal [Category] 대상포진, [키워드] lymphoproliferative disorders Myeloma Risk factors VDJ recombination [DOI] 10.1038/s41408-021-00406-6 PMC 바로가기 [Article Type] Article